[HTML][HTML] Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era
Background The optimal initial therapy of follicular lymphoma (FL) remains unclear. The
aims of this study were to compare primary treatment strategies and assess the impact of …
aims of this study were to compare primary treatment strategies and assess the impact of …
Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era.
CY Cheah, D Chihara, M Ahmed, RE Davis… - Annals of Oncology …, 2016 - europepmc.org
Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD
Anderson Cancer Center in the rituximab era. - Abstract - Europe PMC Sign in | Create an …
Anderson Cancer Center in the rituximab era. - Abstract - Europe PMC Sign in | Create an …
Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era
CY Cheah, D Chihara, M Ahmed, RE Davis… - Annals of …, 2016 - hero.epa.gov
BACKGROUND: The optimal initial therapy of follicular lymphoma (FL) remains unclear. The
aims of this study were to compare primary treatment strategies and assess the impact of …
aims of this study were to compare primary treatment strategies and assess the impact of …
Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era
CY Cheah, D Chihara, M Ahmed… - Annals of …, 2016 - mdanderson.elsevierpure.com
Background: The optimal initial therapy of follicular lymphoma (FL) remains unclear. The
aims of this study were to compare primary treatment strategies and assess the impact of …
aims of this study were to compare primary treatment strategies and assess the impact of …
Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era
CY Cheah, D Chihara, M Ahmed, RE Davis… - Annals of …, 2016 - annalsofoncology.org
Background The optimal initial therapy of follicular lymphoma (FL) remains unclear. The
aims of this study were to compare primary treatment strategies and assess the impact of …
aims of this study were to compare primary treatment strategies and assess the impact of …
Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era
C Cheah, D Chihara, M Ahmed… - Annals of …, 2016 - research-repository.uwa.edu.au
Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD
Anderson Cancer Center in the rituximab era — the UWA Profiles and Research Repository …
Anderson Cancer Center in the rituximab era — the UWA Profiles and Research Repository …
Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era
CY Cheah, D Chihara, M Ahmed… - Annals of oncology …, 2016 - pubmed.ncbi.nlm.nih.gov
Background The optimal initial therapy of follicular lymphoma (FL) remains unclear. The
aims of this study were to compare primary treatment strategies and assess the impact of …
aims of this study were to compare primary treatment strategies and assess the impact of …